Geneia leaders headline population health webinars | Geneia

Geneia leaders headline population health webinars


May 18, 2020


Population Health Alliance: Using AI to Improve Population Health

Harrisburg, PA – Geneia, a healthcare analytic solutions and services company that is simplifying the transition to value-based care, is announcing its leaders are headlining two population health webinars on May 20.

May 20th, 3:00 – 4:00 pm Eastern
Population Health Alliance: Using AI to Improve Population Health

Models created using artificial intelligence (AI) are increasingly being used by physicians, hospital and health plans to predict and prevent unnecessary exacerbations of chronic illness. In this webinar, Geneia chief analytics and technology officer Fred Rahmanian will discuss how these models are developed and review models such as one that predicts which type 2 diabetes patients will experience a diabetes-related complication in the next 12 months, another that predicts which heart failure patients will have complication(s) and a third that identifies patients at high risk for severe COVID-19 impacts.

Geneia’s vice president, consulting services and clinical innovations Shelley Riser will share best practices for putting analytic models into population health practice. She’ll also discuss how she and her team are using a hypertension model to create a more effective, care management program.

To register, click here.

Salesforce Blue Success: The Payer Post-Pandemic Reality: Social Determinants, ID and Strat and Member Engagement

May 20th, 4:00 – 5:00 pm Eastern
Salesforce Blue Success: The Payer Post-Pandemic Reality: Social Determinants, Id and Strat & Member Engagement

In the past two months, healthcare utilization has plummeted. Preventive care has declined precipitously as has emergency care for heart attacks and strokes.

As but one of many examples, a Commonwealth Fund study found “the number of visits to ambulatory practices declined nearly 60 percent in mid-March and has remained low through mid-April.” Contemporaneously, 61 percent of patients report they have been adversely impacted by social determinants of health (SDoH) during the pandemic, a number most experts expect to rise. At the same time, early research has suggested that people with comorbidities like diabetes, hypertension and heart disease are at higher risk for COVID-19 complications and hospitalizations.

These realities put a premium on payers using identification and stratification (id and strat) that integrates social determinants and analytics revealing the members most likely to experience severe COVID-19 impacts. In this webinar, Geneia president and CEO Heather Lavoie and Geneia analytics and technology officer Fred Rahmanian will demonstrate how payers can use enhanced id and strat and member engagement strategies, including the digital front door, to identify and outreach to members with the greatest risk and the most significant gaps in care. They also will discuss payer post-pandemic strategies to determine and engage members in the right dose of care in the most appropriate setting.

Employees of Blue Cross Blue Shield companies are invited to register by clicking here.

ABOUT GENEIA
Geneia LLC is a healthcare analytics and services company. We work to improve collaboration between healthcare providers, health plans and employers to better support personalized, patient-centered care. Through advanced technology, education and training, insights and clinical services, we help clients better identify and actively manage high-risk populations, improve quality measurement and outcomes, and strengthen revenue. Rooted in deep clinical experience and leading-edge data science, our client-centric, phased approach to population health simplifies the transition to risk and value-based care. Our offices are located in Harrisburg, PA and Manchester, NH. To learn more, visit Geneia.com (https://www.geneia.com) or connect with us on Facebook, Twitter and LinkedIn.